{
    "organizations": [],
    "uuid": "f99923b9e75bef8a56b97940266ad0ed02ace1dc",
    "author": "",
    "url": "https://www.reuters.com/article/brief-flex-pharma-reports-q4-loss-per-sh/brief-flex-pharma-reports-q4-loss-per-share-0-46-idUSASB0C95L",
    "ord_in_thread": 0,
    "title": "BRIEF-Flex Pharma Reports Q4 Loss Per Share $0.46",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7, 2018 / 12:05 PM / in 8 minutes BRIEF-Flex Pharma Reports Q4 Loss Per Share $0.46 Reuters Staff March 7 (Reuters) - Flex Pharma Inc: * Q4 REVENUE $283,000 * EXPECTS TO HAVE SUFFICIENT CAPITAL TO FUND ITS OPERATIONS TO MID 2019 Source text for Eikon: Further company coverage:",
    "published": "2018-03-07T14:02:00.000+02:00",
    "crawled": "2018-03-07T14:19:07.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "minute",
        "pharma",
        "report",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "flex",
        "pharma",
        "inc",
        "q4",
        "revenue",
        "expects",
        "sufficient",
        "capital",
        "fund",
        "operation",
        "mid",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}